OngoingEUCTR 2007-001855-20
This study is ongoing in Netherlands. It focuses on ADHD.
ADHDOther
- Countries
- Netherlands
- Sponsor
- Faculty of Social Sciences, Utrecht University
- Condition
- ADHD
OngoingEUCTR 2021-000350-26
This study is ongoing in Spain. It focuses on schizophrenia.
SchizophreniaOther
- Countries
- Spain
- Sponsor
- Oryzon Genomics, S.A.
- Condition
- Schizophrenia
TerminatedNCT01721330
This study has public registry information in the United States. It focuses on ADHD.
ADHDOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Massachusetts General Hospital
- Condition
- ADHD
CompletedNCT00376220
This study is completed in the United States. It focuses on depression in bipolarity.
Bipolarity, DepressionOtherFrom 18 Years to 75 Years
- Countries
- United States
- Sponsor
- Johns Hopkins University
- Condition
- Bipolarity, Depression
CompletedEUCTR 2018-002782-19
This study is completed in the United Kingdom, in Germany, in Hungary, .... It is testing CARIPRAZINE for depression.
DepressionOther
- Countries
- United Kingdom, Germany, Hungary, ...
- Sponsor
- Allergan Ltd.
- Condition
- Depression
CompletedNCT00195845
This study is completed in the United States. It is testing galantamine to Improve Cognitive Dysfunction for Bipolarity.
BipolarityOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Cambridge Health Alliance
- Condition
- Bipolarity
OngoingEUCTR 2017-002227-13
This study is ongoing in France, in the United Kingdom, in Czech Republic, .... It is testing pimavanserin for Schizophrenia.
SchizophreniaOther
- Countries
- France, United Kingdom, Czech Republic, ...
- Sponsor
- ACADIA Pharmaceuticals Inc.
- Condition
- Schizophrenia
CompletedEUCTR 2020-000341-14
This study is completed in the United Kingdom, in Belgium, in Czech Republic, .... It is testing Seltorexant 20 mg for Depression.
DepressionOther
- Countries
- United Kingdom, Belgium, Czech Republic, ...
- Sponsor
- Janssen-Cilag International NV
- Condition
- Depression
TerminatedEUCTR 2010-020493-42
This study has public registry information in Bulgaria, in Poland, in Latvia, .... It is testing vortioxetine for depression.
DepressionOther
- Countries
- Bulgaria, Poland, Latvia, ...
- Sponsor
- H. Lundbeck A/S
- Condition
- Depression
CompletedNCT01094249
This study is completed in the United States. It is testing Valproic Acid and Paliperidone Extended-Release (ER) for schizophrenia.
Bipolarity, SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Condition
- Bipolarity, Schizophrenia
CompletedNCT06297135
This study is completed. It focuses on ADHD and currently lists study information in Japan.
ADHDOther
- Countries
- Japan
- Sponsor
- Okinawa Institute of Science and Technology Graduate University
- Condition
- ADHD
CompletedNCT06679010
This study is completed. It focuses on ADHD and currently lists study information in Denmark.
ADHD, Depression, ...OtherOver 18 Years
- Countries
- Denmark
- Sponsor
- University of Southern Denmark
- Condition
- ADHD, Depression, ...
